MONTREAL--(BUSINESS WIRE)--Caprion Pharmaceuticals Inc.'s Applied BioMedicine group today announced an expansion of a previously established biomarker research collaboration with Vertex Pharmaceuticals Incorporated. The initial collaboration with Vertex was announced in March 2006. The expanded collaboration announced today will continue to apply Caprion’s CellCarta® proteomics biomarker technology across preclinical and clinical development activities being conducted by Vertex.
